Cross-reactivity Between Klebsiella and HLA B27 in Ankylosing Spondylitis

Cross-reactivity Between Klebsiella and HLA B27 in Ankylosing Spondylitis
Author :
Publisher :
Total Pages : 314
Release :
ISBN-10 : OCLC:221075431
ISBN-13 :
Rating : 4/5 ( Downloads)

Book Synopsis Cross-reactivity Between Klebsiella and HLA B27 in Ankylosing Spondylitis by : Christine Marie Ewing

Download or read book Cross-reactivity Between Klebsiella and HLA B27 in Ankylosing Spondylitis written by Christine Marie Ewing and published by . This book was released on 1991 with total page 314 pages. Available in PDF, EPUB and Kindle. Book excerpt:


Cross-reactivity Between Klebsiella and HLA B27 in Ankylosing Spondylitis Related Books

Cross-reactivity Between Klebsiella and HLA B27 in Ankylosing Spondylitis
Language: en
Pages: 314
Authors: Christine Marie Ewing
Categories: Ankylosing spondylitis
Type: BOOK - Published: 1991 - Publisher:

GET EBOOK

Ankylosing spondylitis and Klebsiella
Language: en
Pages: 265
Authors: Alan Ebringer
Categories: Medical
Type: BOOK - Published: 2012-11-08 - Publisher: Springer Science & Business Media

GET EBOOK

Ankylosing spondylitis and Klebsiella is a comprehensive and informative text on the cause of Ankylosing spondylitis. Ankylosing spondylitis (AS) is a condition
Molecular Mimicry
Language: en
Pages: 141
Authors: Michael B.A. Oldstone
Categories: Medical
Type: BOOK - Published: 2013-03-12 - Publisher: Springer Science & Business Media

GET EBOOK

This volume focuses on the evidence for or against molecular mimicry as a cause of autoimmunity. Contributions from recognized experts present their original fi
Crossreactivity Between HLA B27 Lymphocytes and Gram Negative Bacteria
Language: en
Pages: 546
Authors:
Categories:
Type: BOOK - Published: 1981 - Publisher:

GET EBOOK

Molecular Pathogenic Mechanisms of Spondyloarthropathies
Language: en
Pages: 144
Authors: Luis R. Espinoza
Categories: Medical
Type: BOOK - Published: 1995 - Publisher:

GET EBOOK

Summarizes recent events in the understanding of molecular pathogenic mechanisms in spondyloarthropathies, such as better characterization of clinical syndromes